Wen-Yi Huang

Author PubWeight™ 79.98‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Methods for etiologic and early marker investigations in the PLCO trial. Mutat Res 2005 3.33
2 Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst 2008 3.04
3 The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell 2009 2.22
4 Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. Carcinogenesis 2009 2.17
5 Pooled analysis of genetic variation at chromosome 8q24 and colorectal neoplasia risk. Hum Mol Genet 2008 1.96
6 A systematic review of vitamin D receptor gene polymorphisms and prostate cancer risk. J Urol 2006 1.86
7 Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 2008 1.80
8 High-throughput single nucleotide polymorphism genotyping using nanofluidic Dynamic Arrays. BMC Genomics 2009 1.76
9 RNASEL Arg462Gln polymorphism and prostate cancer in PLCO. Prostate 2007 1.74
10 Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 2013 1.58
11 Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study. Cancer Epidemiol Biomarkers Prev 2007 1.58
12 Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. Cancer Res 2006 1.52
13 Tobacco smoking and colorectal hyperplastic and adenomatous polyps. Cancer Epidemiol Biomarkers Prev 2006 1.46
14 Variant in sex hormone-binding globulin gene and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2007 1.27
15 Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts. Cancer Causes Control 2010 1.21
16 A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma. Blood 2009 1.20
17 HER2 codon 655 polymorphism and risk of breast cancer in African Americans and whites. Breast Cancer Res Treat 2003 1.19
18 IGF-1 and IGFBP-3: Risk of prostate cancer among men in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Int J Cancer 2007 1.19
19 Endogenous sex hormones and the risk of prostate cancer: a prospective study. Int J Cancer 2008 1.17
20 Genetic variation in base excision repair genes and the prevalence of advanced colorectal adenoma. Cancer Res 2007 1.15
21 Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Causes Control 2008 1.13
22 Association of energy intake and energy balance with postmenopausal breast cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 2006 1.11
23 Genetic variants of DNA repair genes and prostate cancer: a population-based study. Cancer Epidemiol Biomarkers Prev 2005 1.06
24 A prospective evaluation of C-reactive protein levels and colorectal adenoma development. Cancer Epidemiol Biomarkers Prev 2011 1.06
25 Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer. Cancer Res 2010 1.06
26 GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2005 1.05
27 DNA repair gene polymorphisms and risk of second primary neoplasms and mortality in oral cancer patients. Laryngoscope 2005 1.00
28 CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma. Carcinogenesis 2005 0.99
29 Epidemiologic considerations to assess altered DNA methylation from environmental exposures in cancer. Ann N Y Acad Sci 2003 0.98
30 Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States). Cancer Causes Control 2005 0.98
31 Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer. Cancer Res 2009 0.97
32 A prospective study of serum metabolites and colorectal cancer risk. Cancer 2014 0.96
33 Prospective evaluation of serum sarcosine and risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Carcinogenesis 2013 0.96
34 Non-steroidal anti-inflammatory drug use and colorectal polyps in the Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial. Am J Gastroenterol 2010 0.96
35 Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. J Clin Oncol 2013 0.95
36 Whole blood cryopreservation in epidemiological studies. Cancer Epidemiol Biomarkers Prev 2002 0.95
37 TNF polymorphisms and prostate cancer risk. Prostate 2008 0.95
38 Sugarcane farming, occupational solvent exposures, and the risk of oral cancer in Puerto Rico. J Occup Environ Med 2003 0.93
39 Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Int J Cancer 2014 0.92
40 Association of Coffee Consumption With Overall and Cause-Specific Mortality in a Large US Prospective Cohort Study. Am J Epidemiol 2015 0.91
41 Nitric oxide synthase gene polymorphisms and prostate cancer risk. Carcinogenesis 2009 0.91
42 Diabetes prevalence is associated with serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in US middle-aged Caucasian men and women: a cross-sectional analysis within the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Br J Nutr 2011 0.90
43 Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studies. Carcinogenesis 2007 0.90
44 Iron homeostasis and distal colorectal adenoma risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Prev Res (Phila) 2011 0.90
45 Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer. Prostate 2007 0.89
46 Microsatellite polymorphisms in the epidermal growth factor receptor (EGFR) gene and the transforming growth factor-alpha (TGFA) gene and risk of oral cancer in Puerto Rico. Pharmacogenet Genomics 2005 0.88
47 Variants in the alpha-Methylacyl-CoA racemase gene and the association with advanced distal colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2007 0.88
48 DNA repair gene polymorphisms and tobacco smoking in the risk for colorectal adenomas. Carcinogenesis 2011 0.87
49 The impact of smoking on the severity of acute ischemic stroke. J Neurol Sci 2011 0.87
50 Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Carcinogenesis 2010 0.86
51 Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma. Carcinogenesis 2007 0.86
52 Association of obesity with cardiovascular disease mortality in the PLCO trial. Prev Med 2013 0.85
53 Gouty arthritis in acute cerebrovascular disease. Cerebrovasc Dis 2009 0.84
54 Germline variation in NCF4, an innate immunity gene, is associated with an increased risk of colorectal cancer. Int J Cancer 2013 0.84
55 Lack of association of transforming growth factor-beta1 polymorphisms and haplotypes with prostate cancer risk in the prostate, lung, colorectal, and ovarian trial. Cancer Epidemiol Biomarkers Prev 2007 0.83
56 The association between inflammation-related genes and serum androgen levels in men: the prostate, lung, colorectal, and ovarian study. Prostate 2011 0.82
57 Polymorphisms in the adenomatous polyposis coli (APC) gene and advanced colorectal adenoma risk. Eur J Cancer 2010 0.82
58 Gastrointestinal hemorrhage after acute ischemic stroke and its risk factors in Asians. Eur Neurol 2009 0.82
59 Non-Hodgkin lymphoma (NHL) subtypes defined by common translocations: utility of fluorescence in situ hybridization (FISH) in a case-control study. Leuk Res 2009 0.82
60 Click-chemistry-conjugated oligo-angiomax in the two-dimensional DNA lattice and its interaction with thrombin. Biomacromolecules 2009 0.81
61 Variants of DNA repair genes and the risk of biliary tract cancers and stones: a population-based study in China. Cancer Epidemiol Biomarkers Prev 2008 0.81
62 A case-control study of tobacco use and other non-occupational risk factors for lymphoma subtypes defined by t(14; 18) translocations and bcl-2 expression. Cancer Causes Control 2010 0.80
63 The PLCO Biorepository: Creating, Maintaining, and Administering a Unique Biospecimen Resource. Rev Recent Clin Trials 2015 0.79
64 Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin. Cancer Epidemiol Biomarkers Prev 2010 0.79
65 First-ever ischemic stroke in very old Asians: clinical features, stroke subtypes, risk factors and outcome. Eur Neurol 2007 0.78
66 Xenobiotic metabolizing genes, meat-related exposures, and risk of advanced colorectal adenoma. World Rev Nutr Diet 2010 0.78
67 Genetic variants in frizzled-related protein (FRZB) and the risk of colorectal neoplasia. Cancer Causes Control 2008 0.78
68 PLCO: Evolution of an Epidemiologic Resource and Opportunities for Future Studies. Rev Recent Clin Trials 2015 0.77
69 Less favorable neurological recovery after acute stroke in patients with hypercholesterolemia. Clin Neurol Neurosurg 2013 0.76
70 Clinical characteristics of adult tetanus in a Taiwan medical center. J Formos Med Assoc 2011 0.76
71 Laboratory detective work identifies a mishandling problem in sample aliquoting. Biopreserv Biobank 2014 0.75
72 Innate immunity gene polymorphisms and the risk of colorectal neoplasia. Carcinogenesis 2013 0.75
73 AFM and multiple transmission-reflection infrared spectroscopy (MTR-IR) studies on formation of air-stable supported lipid bilayers. Int J Mol Sci 2009 0.75
74 Xenobiotic metabolizing genes, meat-related exposures, and risk of advanced colorectal adenoma. J Nutrigenet Nutrigenomics 2011 0.75
75 Aspirin use and mortality in two contemporary U.S. cohorts. Epidemiology 2017 0.75
76 Very early hemorrhagic transformation of a subcortical infarction. Acta Neurol Taiwan 2008 0.75